Hydrocodone: Rescheduled, Repositioned & Reinvented

Pain Insights, Inc. releases a comprehensive market research study assessing two major intertwined events in the pain market: the rescheduling of hydrocodone combinations and the pending introduction of abuse-deterrent, extended-release, single-entity hydrocodone products. FAIRFIELD, N.J., Dec. 4, 2014 /PRNewswire/ — The introduction of abuse-deterrent, extended-release hydrocodone products and the rescheduling of hydrocodone combination products (HCPs) will […]

Hydrocodone: Rescheduled, Repositioned & Reinvented

Pain Insights, Inc. releases a comprehensive market research study on the impact of hydrocodone rescheduling, Zohydro™ ER, and abuse-deterrent formulations on prescribers and the pain market. FAIRFIELD, N.J., Oct. 22, 2014 /PRNewswire/ — Rescheduling of hydrocodone combination products (HCPs) will impel a major transformation in the pain market, according to a new primary market research study […]